Home NDC 71904-200 POMBILITI
Product NDC 71904-200
11-digit product format 719040200
Labeler code 71904
Product ID 71904-200_378efc18-b873-47fa-b558-5ea92904a165
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cipaglucosidase alfa-atga
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler AMICUS THERAPEUTICS US, LLC
Application BLA761204
Marketing category BLA
Marketing start 2023-10-11
Substance CIPAGLUCOSIDASE ALFA
Active strength 105 mg/1
Pharmacologic classes Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC], alpha-Glucosidases [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base POMBILITI
Brand name suffix ATGA
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CIPAGLUCOSIDASE ALFA 105 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4SED7F4BSG Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2667440 Internal RxNorm lookup 2667446 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71904-200-01 POMBILITIATGA 105 in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 105 5 71904-200-01 POMBILITIATGA 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 5 71904-200-02 POMBILITIATGA 105 in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 105 5 71904-200-02 POMBILITIATGA 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 5 71904-200-03 POMBILITIATGA 25 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 25 5 71904-200-03 POMBILITIATGA 105 in 1 VIAL, GLASS INJECTION, POWDER, LYOPHILIZED, 105 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71904-200 POMBILITI ATGA (CIPAGLUCOSIDASE ALFA-ATGA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMICUS THERAPEUTICS US, LLC] 5 Current NDC, 6 package rows 20241207_d77aa596-910d-516b-e053-2995a90a0839.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761204 Pombiliti cipaglucosidase alfa-atga 351(a) Rx 2026-08-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 71904-200-01 71904020001 1 VIAL, GLASS in 1 CARTON (71904-200-01) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS 2023-10-11 No No Current 71904-200-02 71904020002 10 VIAL, GLASS in 1 CARTON (71904-200-02) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS 2023-10-11 No No Current 71904-200-03 71904020003 25 VIAL, GLASS in 1 CARTON (71904-200-03) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS 2023-10-11 No No Current